Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1141362

	registered interest
	date	23/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Measles
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what guidance his Department has published on distinguishing between rashes caused by the measles vaccine and those arising from the wild strain of measles.
	tabling member constituency	Gravesham
	tabling member printed	Adam Holloway
	uin	280995
	answer	answer is ministerial correction date of answer 05/08/2019 answer text <p>While post vaccine rash and fever is generally mild, distinguishing from wild-type measles is not based on clinical examination, rather it is based on a combination of laboratory analysis, information on the timing of vaccine and epidemiological information. The national measles guidelines describe the management and investigation of suspected cases of measles, and is available to view at the following link:</p><p><a href="https://www.gov.uk/government/publications/national-measles-guidelines" target="_blank">https://www.gov.uk/government/publications/national-measles-guidelines</a></p><p>Statistics on confirmed measles cases are reported by vaccination status and are available at the following link:</p><p><a href="https://www.gov.uk/government/publications/measles-mumps-and-rubella-lab-confirmed-cases-in-england-2019" target="_blank">https://www.gov.uk/government/publications/measles-mumps-and-rubella-lab-confirmed-cases-in-england-2019</a></p><p> </p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 280996 question first answered 05/08/2019 11:32:33 answering member 4380 label Biography information for Jo Churchill
	tabling member	1522 label Biography information for Adam Holloway

1141363

	registered interest
	date	23/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Measles
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that statistics on the infection rate for measles do not include people who have received the live measles vaccine and contracted a measles-like rash and fever.
	tabling member constituency	Gravesham
	tabling member printed	Adam Holloway
	uin	280996
	answer	answer is ministerial correction date of answer 05/08/2019 answer text <p>While post vaccine rash and fever is generally mild, distinguishing from wild-type measles is not based on clinical examination, rather it is based on a combination of laboratory analysis, information on the timing of vaccine and epidemiological information. The national measles guidelines describe the management and investigation of suspected cases of measles, and is available to view at the following link:</p><p><a href="https://www.gov.uk/government/publications/national-measles-guidelines" target="_blank">https://www.gov.uk/government/publications/national-measles-guidelines</a></p><p>Statistics on confirmed measles cases are reported by vaccination status and are available at the following link:</p><p><a href="https://www.gov.uk/government/publications/measles-mumps-and-rubella-lab-confirmed-cases-in-england-2019" target="_blank">https://www.gov.uk/government/publications/measles-mumps-and-rubella-lab-confirmed-cases-in-england-2019</a></p><p> </p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 280995 question first answered 05/08/2019 11:32:33 answering member 4380 label Biography information for Jo Churchill
	tabling member	1522 label Biography information for Adam Holloway

1141364

	registered interest
	date	23/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	MMR Vaccine: Side Effects
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that (a) body inclusion encephalitis and (b) other adverse events experienced after a measles vaccine are identified in a timely way by healthcare professionals.
	tabling member constituency	Gravesham
	tabling member printed	Adam Holloway
	uin	280997
	answer	answer is ministerial correction date of answer 05/08/2019 answer text <p>The safety of all the United Kingdom’s vaccination programmes is of paramount importance. Any serious side effects are extremely rare, and the large majority of side effects are mild and transient, such as sore arms, headaches and tiredness. We would recommend that all eligible children are vaccinated, as any potential risk of side effects is far outweighed by the benefits of vaccination.</p><p>Healthcare professionals have access to a range of materials, such as ‘Immunisation against infectious disease: the green book’ and Patient Group Directions to support their decision-making in the case of any suspected adverse effects.</p><p>The Medicines and Healthcare products Regulatory Agency (MHRA) operates the ‘Yellow Card Scheme’, which is vital in helping the MHRA monitor the safety of all healthcare products in the UK. This system allows for reporting of any potential adverse events for all medicines, including vaccines, with guidance for healthcare professionals, patients and the public on how to use the scheme.</p><p>In addition, Public Health England (PHE) offers diagnostic services for suspected cases of encephalitis, which is a notifiable condition. Under statutory duty, cases must be reported by healthcare professionals to PHE’s local Health Protection Teams. This can be viewed at the following link:</p><p><a href="https://www.gov.uk/government/collections/notifications-of-infectious-diseases-noids" target="_blank">https://www.gov.uk/government/collections/notifications-of-infectious-diseases-noids</a></p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 05/08/2019 11:34:01 answering member 4380 label Biography information for Jo Churchill
	tabling member	1522 label Biography information for Adam Holloway

1141380

	registered interest
	date	23/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	MMR Vaccine: Safety
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to maintain and improve pharmacovigilance in relation to the MMR vaccine.
	tabling member constituency	Gravesham
	tabling member printed	Adam Holloway
	uin	280998
	answer	answer is ministerial correction date of answer 25/07/2019 answer text <p>As with all vaccines and medicines, the safety of the Measles, Mumps and Rubella (MMR) vaccine remains under continual review by the Medicines and Healthcare products Regulatory Agency (MHRA). The MHRA uses all available sources of evidence in pharmacovigilance, including regular review of suspected adverse reactions submitted through the Yellow Card Scheme, data from clinical and epidemiological studies, the medical literature and information from pharmaceutical companies and other worldwide regulatory authorities. The MHRA’s processes and data analysis systems are regularly evaluated to ensure optimal performance in monitoring the safety of vaccines and medicines.</p><p>The balance of benefits and risks of MMR vaccine remains overwhelmingly favourable.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 25/07/2019 16:35:38 answering member 4065 label Biography information for Dame Jackie Doyle-Price
	tabling member	1522 label Biography information for Adam Holloway

1141381

	registered interest
	date	23/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	MMR Vaccine
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to help ensure (a) transparency and (b) accountability in the process of manufacturing the MMR vaccine.
	tabling member constituency	Gravesham
	tabling member printed	Adam Holloway
	uin	280999
	answer	answer is ministerial correction date of answer 25/07/2019 answer text <p>Two Measles, Mumps and Rubella (MMR) vaccines are licensed for use in the United Kingdom: M-M-RVaxPro and Priorix. Both vaccines are on the National Health Service’s routine immunisation schedule. The quality, safety and efficacy of both M-M-RVaxPro and Priorix have been evaluated before they were given a Marketing Authorisation in Europe, and the Marketing Authorisation Holder for each vaccines is legally required to submit periodic safety update reports to the regulator, which are documents intended to provide an evaluation of the risk-benefit balance of a medicinal product at defined time points after its authorisation. The sites at which the products are manufactured are also required to undergo periodic inspections to ensure that they comply with Good Manufacturing Practices. Each batch of vaccines is tested by an official medicines control laboratory (OMCL). OMCL testing is independent of and in addition to the manufacturer’s testing. These procedures ensure that the MMR vaccines available in the UK are safe and efficacious and that the manufacturers/Marketing Authorisation holders are held accountable for their products.</p><p>A European Public Assessment Report (EPAR) for M-M-RVaxPro is available at the following link:</p><p><a href="https://www.ema.europa.eu/en/documents/scientific-discussion/m-m-rvaxpro-epar-scientific-discussion_en.pdf" target="_blank">https://www.ema.europa.eu/en/documents/scientific-discussion/m-m-rvaxpro-epar-scientific-discussion_en.pdf</a></p><p>Priorix was approved before public assessment reports were a requirement. The EPAR for M-M-RVaxPro contains a general summary of the manufacturing information that was provided during the assessment process; however, the specific details of the manufacturing process are confidential.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 25/07/2019 16:38:57 answering member 4065 label Biography information for Dame Jackie Doyle-Price
	tabling member	1522 label Biography information for Adam Holloway

1141825

	registered interest
	date	24/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	MMR Vaccine
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that parents and carers are provided with accurate information on the benefits and risks of the MMR vaccine.
	tabling member constituency	Gravesham
	tabling member printed	Adam Holloway
	uin	281668
	answer	answer is ministerial correction date of answer 09/09/2019 answer text <p>The National Health Service website has a dedicated page on the measles, mumps and rubella (MMR) vaccine, which can be found at the following link:</p><p><a href="https://www.nhs.uk/conditions/vaccinations/mmr-vaccine/" target="_blank">https://www.nhs.uk/conditions/vaccinations/mmr-vaccine/</a></p><p>In addition, Public Health England provides information on the benefits and risks of the MMR vaccine to the public using NHS branded leaflets, some of which are available in multiple languages. The leaflets address common questions about the MMR vaccine. In addition to parents and carers this information is designed for use by schools, healthcare centres, accident and emergency departments, hospital wards, walk-in centres and general practices.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 09/09/2019 14:56:52 answering member 4380 label Biography information for Jo Churchill
	tabling member	1522 label Biography information for Adam Holloway

1174358

	registered interest
	date	29/01/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	5G: Health Hazards
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department has taken to ensure that public health policy on the effects of the 5G network is based on up-to-date information; and what plans he has to review the guidelines of the International Commission on Non-Ionizing Radiation Protection on exposure to visible and infrared radiation.
	tabling member constituency	Gravesham
	tabling member printed	Adam Holloway
	uin	9619
	answer	answer is ministerial correction date of answer 07/02/2020 answer text <p>Public Health England (PHE) advises the Department on all aspects of public health, including the effects of the 5G network.</p><p>PHE scientific experts keep up-to-date with the latest published evidence and carry out their own research. PHE’s research is published in the academic literature and available to expert groups performing comprehensive evidence reviews. Links to recent reviews can be found at the following link:</p><p><a href="https://www.gov.uk/government/publications/mobile-phone-base-stations-radio-waves-and-health/mobile-phone-base-stations-radio-waves-and-health" target="_blank">https://www.gov.uk/government/publications/mobile-phone-base-stations-radio-waves-and-health/mobile-phone-base-stations-radio-waves-and-health</a></p><p>A revision of the current International Commission on Non-Ionizing Radiation Protection guidelines on exposure to visible and infrared radiation is underway. PHE will consider the new guidelines when published and provide relevant advice.</p><p> </p><p> </p><p> </p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 07/02/2020 11:22:53 answering member 4380 label Biography information for Jo Churchill
	tabling member	1522 label Biography information for Adam Holloway

1184400

	registered interest
	date	11/03/2020
	answering body	Ministry of Defence
	answering dept id	11
	answering dept short name	Defence
	answering dept sort name	Defence
	hansard heading	Defence Infrastructure Organisation and Reserve Forces' and Cadets' Association: Cost Effectiveness
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Defence, what comparative assessment he has made of the cost efficiency of the (a) Reserve Forces and Cadets Association and (b) Defence Infrastructure Organisation working on small projects.
	tabling member constituency	Gravesham
	tabling member printed	Adam Holloway
	uin	27975
	answer	answer is ministerial correction date of answer 18/03/2020 answer text <p>At this time, no comparison of the cost efficiency of these organisations working on small projects has been undertaken.</p> answering member constituency Horsham answering member printed Jeremy Quin question first answered 18/03/2020 15:05:33 answering member 4507 label Biography information for Sir Jeremy Quin
	tabling member	1522 label Biography information for Adam Holloway

1184401

	registered interest
	date	11/03/2020
	answering body	Ministry of Defence
	answering dept id	11
	answering dept short name	Defence
	answering dept sort name	Defence
	hansard heading	Reserve Forces' and Cadets' Associations: Membership
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Defence, what information his Department holds on the skills available free of charge to the Reserve Forces and Cadets' Association through its active volunteer membership.
	tabling member constituency	Gravesham
	tabling member printed	Adam Holloway
	uin	27976
	answer	answer is ministerial correction date of answer 18/03/2020 answer text <p>We greatly value the contribution of the Reserve Forces and Cadets' Association's volunteer membership in support of the Reserve Forces and the Cadet organisations. Their continued contribution of their own free time to support our Armed Forces and affiliated youth organisations is laudable, and we hold them in the highest regard.</p><p>We do not currently hold any information on the skills, qualifications or experience of volunteer members outside of the Armed Forces. We recognise that our volunteers bring a wealth of experience and different ways of working, whilst concurrently being a fully integrated and integral part of our tri-service community and youth organisations.</p> answering member constituency Wells answering member printed James Heappey question first answered 18/03/2020 15:01:20 answering member 4528 label Biography information for James Heappey
	tabling member	1522 label Biography information for Adam Holloway

1184402

	registered interest
	date	11/03/2020
	answering body	Ministry of Defence
	answering dept id	11
	answering dept short name	Defence
	answering dept sort name	Defence
	hansard heading	Reserve Forces' and Cadets' Associations: Membership
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Defence, what steps his Department is taking to ensure that membership of the Reserve Forces and Cadets Association continues to serve (a) reserves and cadets and (b) wider defence policy.
	tabling member constituency	Gravesham
	tabling member printed	Adam Holloway
	uin	27977
	answer	answer is ministerial correction date of answer 18/03/2020 answer text <p>We greatly value the contribution of the Reserve Forces and Cadet Associations (RFCA) to Defence and we continue to engage with their volunteer membership. This is achieved through Ministerial and senior military attendance at events such as the Council of RFCAs' annual briefing, and the Annual General Meetings held by Associations. Such engagement ensures that we maintain links at the appropriate level of seniority, and I am confident that the Ministry of efenceD will maintain its current excellent relationship with the RFCAs long into the future.</p> answering member constituency Wells answering member printed James Heappey question first answered 18/03/2020 15:07:34 answering member 4528 label Biography information for James Heappey
	tabling member	1522 label Biography information for Adam Holloway